PALVELLA THERAPEUTICS, INC. (PVLA) › Operating IncomePALVELLA THERAPEUTICS, INC. (PVLA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: $553.8K2014: -$7.20M2015: -$13.68M2016: -$22.76M2017: -$14.59M2018: -$30.83M2019: -$27.16M2020: -$33.92M2021: -$51.83M2022: -$43.47M2023: -$11.87M2024: -$14.10M2025: -$38.60M-$38.60M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$38.60M-173.9%2024-$14.10M-18.8%2023-$11.87M+72.7%2022-$43.47M+16.1%2021-$51.83M-52.8%2020-$33.92M-24.9%2019-$27.16M+11.9%2018-$30.83M-111.3%2017-$14.59M+35.9%2016-$22.76M-66.4%2015-$13.68M-90.1%2014-$7.20M-1399.7%2013$553.8K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share